Supplier Info Centre > Related news headlines

All news headlines for

Fuji Chemical

Astaxanthin wins Novel Foods approval

02-Jul-2008 - Israeli firm Algatechnologies has won European Union Novel Foods approval for its patented version of the antioxidant astaxanthin, and plans to take the ingredient into new European markets.

Fuji develops excipient for dissolvable tablets

06-May-2008 - Fuji Health Science is launching a new excipient for use in tablets that enables them to dissolve in the mouth in less than 30 seconds - an innovation that presents an alternative to tablets that may be hard-to-swallow.

BioReal ups astaxanthin content and rebrands

17-Apr-2007 - Sweden-based BioReal have launched a new formulation of its algal astaxanthin extract, offering customers a minimum of 10 per cent pure astaxanthin.

Fuji gets DMF for fast dissolving excipient

14-Mar-2007 - Japanese firm Fuji Chemical has been assigned a drug master file (DMF) number for its new excipient for fast-dissolving oral tablets.

Could astaxanthin score a goal in sports nutrition?

05-Jan-2007 - Astavita's inroads into sports nutrition applications for astaxanthin could be of interest to sports nutrition formulators looking to branch into this market.

Astavita gears astaxanthin to sports nutrition

03-Jan-2007 - Astavita's announcement of a sponsorship agreement with United States Triathlon has the company making inroads with astaxanthin into the sports nutrition market.

Healthy opportunity in Asian ingredients sector

14-Sep-2006 - Healthy ingredients, a must-have for any ingredient supplier these days, are just as relevant in Asia as western markets, say companies exhibiting at this week's Fi-Asia in Bangkok.

Fuji bags astaxanthin inflammation patent

24-Jul-2006 - Fuji Chemical Industry has been granted a US patent for the use of astaxanthin to reduce inflammation, enabling the manufacturer to further strengthen its position in the market.

BioReal receives Euro go-ahead for astaxanthin

19-Jul-2006 - BioReal has been given the green light to market its AstaREAL L-10 for supplements in Europe, after the astaxanthin was found to be substantially equivalent to other sources on the market under novels foods legislation.

Fuji reformulates AstaREAL for vegetarians

23-Jun-2006 - Fuji Health Sciences has reformulated its AstaREAL powder to exclude components of animal origin - a move that will open up more uses of the ingredient in supplements that are suitable for vegetarians.

Cyanotech counts on China for astaxanthin expansion

11-Jan-2006 - Cyanotech has signed a deal with a distribution company in China that will see its astaxanthin ingredient sold in the promising market for the first time - for both human nutrition and aquaculture.

Industry prepares for increased astaxanthin demand

26-Jul-2005 - Demand for natural astaxanthin in the United States is set to grow apace over the next 18 months, according to Fuji Health Science, due to increased consumer awareness and media attention to its antioxidant properties.